Carcinogenesis Advance Access published online on May 29, 2009
Carcinogenesis, doi:10.1093/carcin/bgp129
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Increased PEA3/E1AF and Decreased Net/Elk-3, both Ets Proteins, Characterize Human NSCLC Progression and Regulate Caveolin-1 Transcription in Calu-1 and NCI-H23 NSCLC Cell Lines
Sloan, Karin; Boston University School of Medicine, Pulmonary Center
Marquez, Hector; Boston University School of Medicine, Medicine
Li, Jun; Boston University School of Medicine, Pulmonary Center
Cao, Yuxia; Boston University School of Medicine, Pulmonary Center
Hinds, Anne; Boston University School of Medicine, Pulmonary Center
O'Hara, Carl; Boston University School of Medicine, Pathology
Kathuria, Satinder; Edward Hines, Jr. VA Hospital, Pathology
Ramirez, Maria; Boston University School of Medicine, Pulmonary Center
Williams, Mary; Boston University School of Medicine, Pulmonary Center
Kathuria, Hasmeena; Boston University School of Medicine, Pulmonary Center
Corresponding Author and Contact Details. kasloan{at}bu.edu, Boston University School of Medicine, Pulmonary Center, R304, 72 E. Concord St., Boston, MA 02118, 617-638-4860
Caveolin-1 protein has been called a "conditional tumor suppressor" because it can either suppress or enhance tumor progression depending on cellular context. Caveolin-1 levels are dynamic in non-small cell lung cancer (NSCLC), with increased levels in metastatic tumor cells. We have previously shown that transactivation of an ETS cis-element enhances caveolin-1 expression in a murine lung epithelial cell line. Based on high sequence homology between the murine and human caveolin-1 promoters, we proposed that ETS proteins might regulate caveolin-1 expression in human lung tumorigenesis. We confirm that caveolin-1 is not detected in well-differentiated primary lung tumors. PEA3, a pro-metastatic ETS protein in breast cancer, is expressed at low levels in well-differentiated tumors and high levels in poorly-differentiated tumors. Conversely, Net, a known ETS repressor, is expressed at high levels in the nucleus of well-differentiated primary tumor cells. In tumor cells in metastatic lymph node sites, caveolin-1 and PEA3 are highly expressed, whereas Net is now expressed in the cytoplasm. We studied transcriptional regulation of caveolin-1 in two human lung cancer cell lines, Calu-1 (high caveolin-1 expressing) and NCI-H23 (low caveolin-1 expressing). ChIP binding assays, and siRNA experiments show that PEA3 is a transcriptional activator in Calu-1 cells and that Net is a transcriptional repressor in NCI-H23 cells. These results suggest that Net may suppress caveolin-1 transcription in primary lung tumors and that PEA3 may activate caveolin-1 transcription in metastatic lymph nodes.
Received November 14, 2008; revised May 15, 2009; accepted May 16, 2009.